Holdings of Invesco Nasdaq Biotechnology ETF
Invesco Exchange-Traded Fund Trust II · Original filing · Compare with another fund · Report an error
- Net assets
- 75.7M $ including 75.6M $ in equities, 99.9 %
- Positions
- 261 in 18 countries
- Top ten
- 46.7 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 201 | Aquestive Therapeutics Inc | 6,813 | 27.3K $ | 0.04 % |
| 202 | Solid Biosciences Inc | 4,366 | 27.1K $ | 0.04 % |
| 203 | Galapagos NV | 803 | 27K $ | 0.04 % |
| 204 | Invivyd Inc | 15,472 | 26.1K $ | 0.03 % |
| 205 | Prothena Corp PLC | 2,992 | 25.9K $ | 0.03 % |
| 206 | SIGA Technologies Inc | 3,989 | 25.8K $ | 0.03 % |
| 207 | Eton Pharmaceuticals Inc | 1,510 | 25.7K $ | 0.03 % |
| 208 | REGENXBIO Inc | 2,835 | 25.6K $ | 0.03 % |
| 209 | Fulcrum Therapeutics Inc | 3,042 | 25.5K $ | 0.03 % |
| 210 | Entrada Therapeutics Inc | 2,126 | 25.4K $ | 0.03 % |
| 211 | Larimar Therapeutics Inc | 4,770 | 25.3K $ | 0.03 % |
| 212 | Altimmune Inc | 5,817 | 25.1K $ | 0.03 % |
| 213 | Tectonic Therapeutic Inc | 1,045 | 24.5K $ | 0.03 % |
| 214 | Keros Therapeutics Inc | 1,724 | 24.5K $ | 0.03 % |
| 215 | PepGen Inc | 3,853 | 24K $ | 0.03 % |
| 216 | LENZ Therapeutics Inc | 1,768 | 23.9K $ | 0.03 % |
| 217 | Upstream Bio Inc | 3,038 | 23.3K $ | 0.03 % |
| 218 | Absci Corp | 8,394 | 23K $ | 0.03 % |
| 219 | Enanta Pharmaceuticals Inc | 1,604 | 22.9K $ | 0.03 % |
| 220 | Anavex Life Sciences Corp | 4,989 | 22.1K $ | 0.03 % |
| 221 | Aura Biosciences Inc | 3,566 | 21K $ | 0.03 % |
| 222 | Atea Pharmaceuticals Inc | 4,376 | 20.5K $ | 0.03 % |
| 223 | Kyverna Therapeutics Inc | 2,433 | 20K $ | 0.03 % |
| 224 | Neurogene Inc | 848 | 19.9K $ | 0.03 % |
| 225 | Contineum Therapeutics Inc | 1,293 | 19.8K $ | 0.03 % |
| 226 | Autolus Therapeutics PLC | 11,218 | 19.2K $ | 0.03 % |
| 227 | NovaBridge Biosciences | 5,799 | 19K $ | 0.03 % |
| 228 | Immuneering Corp | 3,615 | 18K $ | 0.02 % |
| 229 | Foghorn Therapeutics Inc | 3,158 | 17.9K $ | 0.02 % |
| 230 | Cabaletta Bio Inc | 5,395 | 17.9K $ | 0.02 % |
| 231 | Aclaris Therapeutics Inc | 6,047 | 17.4K $ | 0.02 % |
| 232 | AC Immune SA | 5,590 | 16.4K $ | 0.02 % |
| 233 | Candel Therapeutics Inc | 3,078 | 16.2K $ | 0.02 % |
| 234 | Puma Biotechnology Inc | 2,824 | 16.1K $ | 0.02 % |
| 235 | Evolus Inc | 3,626 | 15.6K $ | 0.02 % |
| 236 | Aardvark Therapeutics Inc | 1,232 | 15.4K $ | 0.02 % |
| 237 | Lifecore Biomedical Inc | 2,092 | 15.1K $ | 0.02 % |
| 238 | Bicycle Therapeutics PLC | 2,589 | 14.8K $ | 0.02 % |
| 239 | Vor BioPharma Inc | 960 | 14.8K $ | 0.02 % |
| 240 | C4 Therapeutics Inc | 5,430 | 14.7K $ | 0.02 % |
| 241 | Silence Therapeutics PLC | 2,621 | 14.3K $ | 0.02 % |
| 242 | OmniAb Inc | 8,054 | 13.9K $ | 0.02 % |
| 243 | Orchestra BioMed Holdings Inc | 3,155 | 13.8K $ | 0.02 % |
| 244 | Arcturus Therapeutics Holdings Inc | 1,610 | 13.3K $ | 0.02 % |
| 245 | Voyager Therapeutics Inc | 3,162 | 13K $ | 0.02 % |
| 246 | Humacyte Inc | 10,465 | 11.7K $ | 0.02 % |
| 247 | Editas Medicine Inc | 5,197 | 11.4K $ | 0.02 % |
| 248 | Coherus Oncology Inc | 6,762 | 11.3K $ | 0.01 % |
| 249 | Quantum-Si Inc | 10,933 | 10.5K $ | 0.01 % |
| 250 | Sagimet Biosciences Inc | 1,749 | 10K $ | 0.01 % |
| 251 | Caribou Biosciences Inc | 5,225 | 9.9K $ | 0.01 % |
| 252 | Jyong Biotech Ltd. | 4,238 | 9.1K $ | 0.01 % |
| 253 | Black Diamond Therapeutics Inc | 3,178 | 7.8K $ | 0.01 % |
| 254 | Alpha Teknova Inc | 2,973 | 7.7K $ | 0.01 % |
| 255 | Rani Therapeutics Holdings Inc | 5,458 | 7.5K $ | 0.01 % |
| 256 | Gossamer Bio Inc | 12,911 | 5.5K $ | 0.01 % |
| 257 | Codexis Inc | 5,176 | 5.2K $ | 0.01 % |
| 258 | Tenaya Therapeutics Inc | 9,284 | 5.2K $ | 0.01 % |
| 259 | Pyxis Oncology Inc | 3,526 | 5.2K $ | 0.01 % |
| 260 | CARTESIAN THERAPEUTICS INC | 2,633 | 359.2 $ | 0.00 % |
| 261 | Third Harmonic Bio Inc | 1,661 | 49.8 $ | 0.00 % |
Sector breakdown
- Health care 53.0 %
- Unattributed 47.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 89.4 %
- Netherlands 2.2 %
- Bermuda 1.5 %
- France 1.5 %
- Ireland 1.3 %
- Denmark 1.2 %
- Germany 0.8 %
- Canada 0.6 %
- Switzerland 0.5 %
- Cayman Islands 0.3 %
- Singapore 0.2 %
- Jersey 0.1 %
- Other countries 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 225 | 67.7M $ | 89.44 % |
| 2 | Netherlands | 4 | 1.6M $ | 2.18 % |
| 3 | Bermuda | 1 | 1.1M $ | 1.51 % |
| 4 | France | 2 | 1.1M $ | 1.50 % |
| 5 | Ireland | 4 | 1M $ | 1.34 % |
| 6 | Denmark | 2 | 906.7K $ | 1.20 % |
| 7 | Germany | 1 | 631.2K $ | 0.83 % |
| 8 | Canada | 4 | 450.4K $ | 0.60 % |
| 9 | Switzerland | 2 | 342.2K $ | 0.45 % |
| 10 | Cayman Islands | 5 | 193.3K $ | 0.26 % |
| 11 | Singapore | 1 | 130.3K $ | 0.17 % |
| 12 | Jersey | 1 | 85.6K $ | 0.11 % |
Cite this page
Titelia. "Holdings of Invesco Nasdaq Biotechnology ETF". https://titelia.com/en/funds/S000072469